Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study.

Authors :: Cortes JE
Lipton JH
Kota V
Castagnetti F
Assouline S
Brümmendorf TH
Leip E
Viqueira A
Gambacorti-Passerini C
Source :: Haematologica [Haematologica] 2023 Dec 01; Vol. 108 (12), pp. 3454-3459. Date of Electronic Publication: 2023 Dec 01.
Publication Year :: 2023

Subjects :: Humans
Philadelphia Chromosome
Tyrosine Kinase Inhibitors
Imatinib Mesylate therapeutic use
Nitriles therapeutic use
Protein Kinase Inhibitors adverse effects
Leukemia drug therapy
Antineoplastic Agents adverse effects

Full Text Access

Tools